Los Angeles [US], June 19 (ANI): According to UCLA scientists working with Stanford and University of Pennsylvania experts, a synthetic IL-9 receptor permits cancer-fighting T cells to accomplish their job without the usage of chemo or radiation.
Washington [US], June 9 (ANI): According to a study by the University of California-Los Angeles Health Science, before a patient can undergo T cell therapy designed to target cancerous tumours, the patient's entire immune system must be destroyed with chemotherapy or radiation.
\
\
\
\
